Löschung

Hintereinander ist der Kurs gestiegen ohne News.

www.globenewswire.com/news-release/2020/05/...-2-Peptides.html

Hat gnbt jetzt die erzeugten Peptide patentiert?
in paar Monaten wird klar ob diese Firma etwas gutes erzeugen kann oder nicht

www-fool-com.cdn.ampproject.org/c/s/...ery-coronavirus-v.aspx

www.sec.gov/Archives/edgar/data/1804585/...0-000154-index.htm

On June 23, 2020, NuGenerex Immuno-Oncology, Inc. (“NGIO”) entered into a term sheet (“Term Sheet”) with an institutional accredited investor (the “Investor”) pursuant to which the Investor committed to purchase up to $50,000,000 (the “Maximum Amount”) of NGIO’s common stock (the “Financing”), subject to mutual agreement of final documentation between NGIO and Investor (“Purchase Agreement”). NGIO anticipates closing the final documentation within the next 7 to 10 business days. If a Purchase Agreement is signed, then upon filing and effectiveness of NGIO’s Registration Statement on Form S-1 and provided other closing conditions are met, from time to time over the term of the Purchase Agreement, NGIO shall have the right, but not the obligation, to direct the Investor to purchase shares of NGIO’s common stock without a discount (the “Put Shares”). In addition to filing a Form S-1 for this Financing transaction with Investor, NGIO intends to submit an application to NASDAQ for listing and file an “IPO” Registration Statement on Form S-1 to get NGIO’s going concern off, which this Financing will support such NASDAQ listing. A copy of the Term Sheet is attached to this report as Exhibit 99.1 and is incorporated by reference herein.

www.bloomberg.com/press-releases/...l-july-10-2020-at-4-15-pm

Hat niemand hier eine Meinung über diese Firma, ob sie mehr wert ist als eine Spekulation?

eine gute neuigkeit hat es noch nicht gegeben.
die entscheidung von barda ist noch abzuwarten  

NuGenerex Immuno-Oncology (NuGenerex IO), today announced the closing of a $50 Million equity financing facility to support the company’s strategic and development plans. NuGenerex IO is now a public company, and once the S1 registration for this $50 Million is filed, and a subsequent S1 for an equity raise is filed in collaboration with its investment bank, the company plans to immediately apply for a listing on either the Nasdaq or NY Stock exchanges. The requisite 8k on this closing will be filed accordingly.

das heißt, die wollen ihr Impfstoff an Menschen testen?

www.bloomberg.com/press-releases/...cine-against-the-covid-19

www.bloomberg.com/press-releases/...ii-key-sars-cov-2-vaccine

onedrive.live.com/...CFFBA2%214267&parId=root&o=OneUp